These three websites offer up almost half a million free Zoom backgrounds for your perusal, so forget tidying up and get that ...
How does the cost-effectiveness of treatments, particularly in relation to newer therapies, influence your recommendations for patients with BCG-unresponsive NMIBC? Are there specific tools or ...
BCG, however, anticipates this spending to increase in 2025. Yet, assuming that global counterparts will also keep up with increased spending, this may mean that in India, where supply often ...
India is emerging as a leader in artificial intelligence (AI) investment and adoption, according to the latest AI Radarton Consulting Group (BCG) report from Bos. This report reveals that 80% of ...
An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time oncology review, expediting access to this potential treatment. The FDA has ...
According to the BCG report, India’s total trade and gross domestic product (GDP) will grow 6.4% annually between 2023 and 2033 propelled by “China+1” trade and imports to meet demand from a ...